TSA Versus RSA in Patients >75

Overview

Total shoulder arthroplasty (TSA) has proven to be a predictable and successful operation for the treatment of symptomatic glenohumeral osteoarthritis (GHOA) with an intact rotator cuff. Results after TSA have not been as good in cases with rotator cuff dysfunction, however. Early glenoid loosening, shoulder pain and the need for revision surgery has been all associated with rotator cuff deficiency. Even in cases without tears, fatty infiltration of the rotator cuff has been associated with inferior outcomes in TSA. Advanced age has been shown to be associated with increased fatty infiltration of the rotator cuff in shoulders with primary osteoarthritis. Because of this, one may propose that surgeons should avoid the potential complications with TSA and perform RSA for patients with advanced age. It is thus the purpose of this study to evaluate the patient reported outcomes (PROs) of total shoulder arthroplasty (TSA) compared with reverse shoulder arthroplasty (RSA) in patients >75 years of age

Full Title of Study: “A Prospective Randomized Clinical Trial Comparing Total Shoulder Arthroplasty vs Reverse Shoulder Arthroplasty in Patients >75 Years of Age”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: April 15, 2022

Interventions

  • Procedure: Reverse Total Shoulder Replacement
    • Participants will be randomized to a reverse total shoulder replacement
  • Procedure: Anatomic Total Shoulder Replacement
    • Participants will be randomized to an anatomic total shoulder replacement

Arms, Groups and Cohorts

  • Active Comparator: Reverse total shoulder replacement
    • Participants will receive a reverse total shoulder arthroplasty
  • Active Comparator: Anatomic total shoulder replacement
    • Participants will receive an anatomic total shoulder arthroplasty

Clinical Trial Outcome Measures

Primary Measures

  • Postoperative satisfaction
    • Time Frame: 2 years
    • Investigators will be measuring whether there is an increase in participants satisfaction after surgery as assessed by the American Shoulder and Elbow Score (ASES)
  • Postoperative Satisfaction
    • Time Frame: 2 years
    • Investigators will be measuring whether there is an increase in participants satisfaction after surgery as assessed by the Simple Shoulder Test (SST)
  • Postoperative Pain
    • Time Frame: 2 years
    • Investigators will be measuring whether there is an increase in participants satisfaction after surgery as assessed by the Visual Analog Scale (VAS)

Participating in This Clinical Trial

Inclusion Criteria

  • All patients (75 years of age) at the time of surgery – Patient is willing to participate by complying with pre and postoperative visit requirements – Patient is willing to consent for enrollment – Patient has advanced imaging (CT or MRI) that demonstrates an intact rotator cuff Exclusion Criteria:

  • Patients under the age of 75 – Need for any structural graft for repair of the shoulder during surgery – Current infection of the proximal humerus or scapula – Proximal humerus fracture – Inadequate or malformed bone that precludes adequate support for prosthesis (B2, B3, C Glenoid morphology) – Neuromuscular disorder that does not allow control of the shoulder joint – Significant injury to the brachial plexus – Diagnosis of inflammatory arthropathy – Preoperative diagnosis of full thickness rotator cuff tear – >Goutallier Stage 1 rotator cuff atrophy – Prior shoulder arthroplasty – Non-functioning deltoid muscle – Patients who are known drug or alcohol abuser, or have a psychological disorder as defined by the DSM4 that could affect follow-up care – Patient is a prisoner – Patients who are currently involved in any personal injury litigation, or worker's compensation claims.

Gender Eligibility: All

Minimum Age: 75 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Rothman Institute Orthopaedics
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.